Notably, although Bud/Form alone or with Tio reduced circulating CRP levels in COPD patients in our study, none of the four inhalation treatments showed the effect of intervening other systemic inflammation biomarkers including IL-8, SAA, TNF-α, Fib and WBC. This evidence concerns the gene CXCL8 and chronic obstructive pulmonary disease.